KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Shares Issued (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Shares Issued for 12 consecutive years, with $65000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Shares Issued fell 99.34% to $65000.0 in Q4 2024 year-over-year; TTM through Dec 2025 was $111000.0, a 45.05% decrease, with the full-year FY2025 number at $18000.0, down 91.09% from a year prior.
  • Shares Issued was $65000.0 for Q4 2024 at Biolife Solutions, up from $46000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $100.2 million in Q3 2020 to a low of -$100.2 million in Q4 2020.
  • A 5-year average of $551894.7 and a median of $65000.0 in 2024 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 18024.23% in 2020; the steepest drop was 16057.17% in 2020.
  • Biolife Solutions' Shares Issued stood at -$100.2 million in 2020, then surged by 98.99% to -$1.0 million in 2021, then soared by 69.81% to -$307000.0 in 2022, then soared by 3316.29% to $9.9 million in 2023, then crashed by 99.34% to $65000.0 in 2024.
  • Per Business Quant, the three most recent readings for BLFS's Shares Issued are $65000.0 (Q4 2024), $46000.0 (Q3 2024), and $91000.0 (Q2 2024).